Research and Markets (http://www.researchandmarkets.com/research/nd6fk6/acute_heart) has announced the addition of the "Acute Heart Failure-Pipeline Insights, 2014" subscription to their offering.
This Acute Heart Failure-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Acute Heart Failure.
This report provides information on the therapeutic development based on the Acute Heart Failure dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Acute Heart Failure Overview
- Acute Heart Failure Pipeline Therapeutics
- Acute Heart Failure Therapeutics under Development by Companies
- Acute Heart Failure Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Acute Heart Failure Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Acute Heart Failure Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Acute Heart Failure Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Acute Heart Failure - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Acute Heart Failure - Discontinued Products
- Acute Heart Failure - Dormant Products
- Companies Involved in Therapeutics Development for Acute Heart Failure
- Appendix
For more information visit http://www.researchandmarkets.com/research/nd6fk6/acute_heart
